Highlights MeiraGTx Holdings plc

Equities

MGTX

KYG596651029

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-10 EDT			5-day change	1st Jan Change
5.07 ^USD	-0.59%		+1.40%	-27.78%

05-09	Earnings Flash (MGTX) MEIRAGTX Reports Q1 Revenue $697,000	MT
05-09	MeiraGTx Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (MGTX) MEIRAGTX Reports Q1 Revenue $697,000	05-09	MT
MeiraGTx Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
MeiraGTx Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
North American Morning Briefing : Inflation Data -2-	03-12	DJ
MeiraGTx Holdings Shares Rise on Sale of Remaining Bota-vec Interests to Janssen Pharmaceuticals for Up to $415 Million	12-21	MT
Janssen Pharmaceuticals, Inc. agreed to acquire Assets of MeiraGTx Holdings plc from MeiraGTx Holdings plc for approximately $130 million.	12-20	CI
MeiraGTx Holdings plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
MeiraGT Receives $30 Million Strategic Investment from Sanofi; to Seek Further Strategic Opportunities	23-10-30	MT
MeiraGTx Gets $30 Million Investment From Sanofi	23-10-30	DJ
MeiraGTx Holdings plc Announces an Oral Presentation and Eight Posters At the European Society of Gene and Cell Therapy 2023 Annual Congress	23-10-24	CI
North American Morning Briefing : Treasury Yields Keep Pushing Higher	23-08-17	DJ
MeiraGTx Holdings plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
MeiraGTx Gets Irish Regulator's Authorization for Quality Control Testing at Manufacturing Facility	23-07-19	MT
MeiraGTx Holdings plc Announces Positive Clinical Data from the AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia	23-06-27	CI
MeiraGTx Holdings plc to Present 12-Month Data from All Cohorts of the Completed Phase 1 AQUAx Clinical Study	23-06-22	CI
MeiraGTx Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
MEIRAGTX HOLDINGS PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-14	AQ
MeiraGTx Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
MeiraGTx Holdings plc cAnnounces Positive Clinical Data from the AQUAx Phase 1 Clinical Study of AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia	22-12-13	CI
MeiraGTx Holdings plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights MeiraGTx Holdings plc

Equities

MGTX

KYG596651029

Highlights

Filters